Natural Capsules Limited
Bombay Stock ExchangeTotal Valuation
Natural Capsules Limited carries a market capitalization of 1.53B, placing it among publicly traded companies globally. Its enterprise value stands at 2.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.53B |
| Enterprise Value | 2.73B |
Share Statistics
Natural Capsules Limited currently has 10.39M shares outstanding.
| Shares Outstanding | 10.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.80, and the price-to-book ratio stands at 14.37.
| PE Ratio | N/A |
| PS Ratio | 0.80 |
| PB Ratio | 14.37 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Natural Capsules Limited trades at an EV/EBITDA multiple of 94.13 and an EV/FCF ratio of 28.23. The EV/Sales ratio of 1.46 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 94.13 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.46 |
| EV / EBITDA | 94.13 |
| EV / EBIT | 94.13 |
| EV / FCF | 28.23 |
Financial Position
Natural Capsules Limited maintains a current ratio of 1.03, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 49.20, indicating elevated leverage, while an interest coverage ratio of -1.71 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.03 |
| Quick Ratio | 0.04 |
| Debt / Equity | 49.20 |
| Debt / EBITDA | -6.17 |
| Interest Coverage | -1.71 |
Financial Efficiency
| Return on Equity (ROE) | -49.22 |
| Return on Assets (ROA) | -5.85 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.95 |
Taxes
| Income Tax | -32.57M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Natural Capsules Limited's stock has declined approximately -33.02961% over the past 52 weeks. The 50-day moving average sits at 157.09, while the 200-day moving average is 176.38.
| Beta (5Y) | N/A |
| 52-Week Price Change | -33.02961% |
| 50-Day Moving Average | 157.09 |
| 200-Day Moving Average | 176.38 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Natural Capsules Limited generated 1.87B in revenue and converted that into -246.63M in net income, yielding earnings per share of -23.86. EBITDA reached -187.03M, while operating income came in at -187.03M.
| Revenue | 1.87B |
| Gross Profit | 848.57M |
| Operating Income | -187.03M |
| Pretax Income | -279.20M |
| Net Income | -246.63M |
| EBITDA | -187.03M |
| EBIT | -187.03M |
| Earnings Per Share (EPS) | -23.86 |
Balance Sheet
Natural Capsules Limited holds 48.23M in cash and equivalents against 1.15B in total debt, resulting in a net debt position of 1.14B. Total book value stands at 103.86M, with working capital of 40.70M providing operational flexibility.
| Cash & Cash Equivalents | 48.23M |
| Total Debt | 1.15B |
| Net Debt | 1.14B |
| Equity (Book Value) | 103.86M |
| Book Value Per Share | 10.05 |
| Working Capital | 40.70M |
Margins
Natural Capsules Limited operates with a gross margin of 45.33, reflecting its pricing power and cost economics. The operating margin of -9.99 and net profit margin of -13.17 provide insight into operational efficiency.
| Gross Margin | 45.33 |
| Operating Margin | -9.99 |
| Pretax Margin | -14.91 |
| Profit Margin | -13.17 |
| EBITDA Margin | -9.99 |
Stock Splits
Natural Capsules Limited's most recent stock split took place on November 11, 2021 with a 1000:1219 split ratio.
| Last Split Date | 11/11/2021 |
| Split Ratio | 1000:1219 |
Scores
Natural Capsules Limited posts an Altman Z-Score of 0.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.78 |